LIXT
Price:
$2.09
Market Cap:
$4.70M
Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers; and encompasses two major categories of compounds at various stages of pre-clinical and clinical development. It develops two series of pharmacologically active drugs, which include the LB-100 series that consists of novel structures for the treatment of cancers, and vascular and metabolic diseases; and L...[Read more]
Industry
Biotechnology
IPO Date
2007-10-25
Stock Exchange
NASDAQ
Ticker
LIXT
According to Lixte Biotechnology Holdings, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 5.13. This represents a change of -36.87% compared to the average of 8.13 of the last 4 quarters.
The mean historical Current Ratio of Lixte Biotechnology Holdings, Inc. over the last ten years is 11.03. The current 5.13 Current Ratio has changed 4.56% with respect to the historical average. Over the past ten years (40 quarters), LIXT's Current Ratio was at its highest in in the March 2021 quarter at 32.55. The Current Ratio was at its lowest in in the September 2018 quarter at 0.96.
Average
11.03
Median
12.48
Minimum
1.97
Maximum
24.15
Discovering the peaks and valleys of Lixte Biotechnology Holdings, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 460.35%
Maximum Annual Current Ratio = 24.15
Minimum Annual Increase = -45.35%
Minimum Annual Current Ratio = 1.97
Year | Current Ratio | Change |
---|---|---|
2023 | 13.73 | -2.53% |
2022 | 14.08 | -16.24% |
2021 | 16.81 | -30.37% |
2020 | 24.15 | 114.99% |
2019 | 11.23 | -45.35% |
2018 | 20.55 | 460.35% |
2017 | 3.67 | 85.02% |
2016 | 1.98 | -5.31% |
2015 | 2.09 | 6.14% |
2014 | 1.97 | 13.73% |
The current Current Ratio of Lixte Biotechnology Holdings, Inc. (LIXT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
14.88
5-year avg
16.00
10-year avg
11.03
Lixte Biotechnology Holdings, Inc.’s Current Ratio is greater than Allarity Therapeutics, Inc. (2.75), greater than NeuroBo Pharmaceuticals, Inc. (2.41), greater than Hillstream BioPharma, Inc. (2.25), less than Virax Biolabs Group Limited (25.94), greater than Quoin Pharmaceuticals, Ltd. (3.02), greater than Indaptus Therapeutics, Inc. (3.42), less than Pasithea Therapeutics Corp. (14.81), greater than Kiromic BioPharma, Inc. (0.22), greater than Biodexa Pharmaceuticals Plc (2.16), less than PMV Pharmaceuticals, Inc. (13.98), less than Olema Pharmaceuticals, Inc. (7.10), greater than Enochian Biosciences, Inc. (0.08), greater than Scholar Rock Holding Corporation (3.88), less than Passage Bio, Inc. (5.15),
Company | Current Ratio | Market cap |
---|---|---|
2.75 | $4.61M | |
2.41 | $20.33M | |
2.25 | $4.17M | |
25.94 | $8.34M | |
3.02 | $2.64M | |
3.42 | $10.68M | |
14.81 | $3.37M | |
0.22 | $1.42M | |
2.16 | $887.52M | |
13.98 | $78.14M | |
7.10 | $360.98M | |
0.08 | $45.38M | |
3.88 | $4.12B | |
5.15 | $40.03M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lixte Biotechnology Holdings, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Lixte Biotechnology Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Lixte Biotechnology Holdings, Inc.'s Current Ratio?
How is the Current Ratio calculated for Lixte Biotechnology Holdings, Inc. (LIXT)?
What is the highest Current Ratio for Lixte Biotechnology Holdings, Inc. (LIXT)?
What is the 3-year average Current Ratio for Lixte Biotechnology Holdings, Inc. (LIXT)?
What is the 5-year average Current Ratio for Lixte Biotechnology Holdings, Inc. (LIXT)?
How does the current Current Ratio for Lixte Biotechnology Holdings, Inc. (LIXT) compare to its historical average?